FERTIGYN
Board
1 director, no change since 2020Director (not named in the articles)
appointed by deed of 20-02-2020
earlier manager, until 20-02-2020
listed in the 2024 annual accounts, filed on 05-08-2025
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
-
- Manager, from before 22-01-2015 to 20-02-2020
- Director (not named in the articles), appointed by deed of 20-02-2020, still in office
Control
Subscriber
This company
FERTIGYN
Equity €906,105
Profit €206,068 in 2025
Capital
- Contribution
- €92,986.80
- Shares
- 3,751
- Contribution per share
- €24.79
- Equity per share
- €242 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 20-02-2020 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Ne peut pas être versé au détriment autres actionnaires, frais généraux indépendamment frais représentation voyages déplacements”
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Médecins exerçant déjà ou appelés à exercer profession de médecin dans cadre sociétaire, accord unanime”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Saturday of June at 10:00
Shareholders
After the capital increase
deed of 19-12-2013 ↗
- 3,001 shares
Capital transactions
Capital over time
- 20-02-2020 Converted to unavailable equity
- 19-12-2013 Capital increase of €74,394.79 · to €92,986.79 · 3,001 new shares at €24.79 per share, 80% of the 3,751 shares after the increase · in cash